118-LB: Glucose Variability throughout the Menstrual Cycle on Closed-Loop Control in Type 1 DM

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 118-LB
Author(s):  
CAROL J. LEVY ◽  
GRENYE OMALLEY ◽  
SUE A. BROWN ◽  
DAN RAGHINARU ◽  
YOGISH C. KUDVA ◽  
...  
2019 ◽  
Vol 80 ◽  
pp. 202-210 ◽  
Author(s):  
Jose Garcia-Tirado ◽  
John P. Corbett ◽  
Dimitri Boiroux ◽  
John Bagterp Jørgensen ◽  
Marc D. Breton

2020 ◽  
Vol 2 (2) ◽  
pp. e64-e73 ◽  
Author(s):  
Boris P Kovatchev ◽  
Laura Kollar ◽  
Stacey M Anderson ◽  
Charlotte Barnett ◽  
Marc D Breton ◽  
...  

2019 ◽  
Vol 21 (6) ◽  
pp. 356-363 ◽  
Author(s):  
Stacey M. Anderson ◽  
Bruce A. Buckingham ◽  
Marc D. Breton ◽  
Jessica L. Robic ◽  
Charlotte L. Barnett ◽  
...  

2007 ◽  
Vol 1 (6) ◽  
pp. 834-841 ◽  
Author(s):  
Stephen D. Patek ◽  
Marc D. Breton ◽  
Yuanda Chen ◽  
Chad Solomon ◽  
Boris Kovatchev

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Xiaoteng Gao ◽  
Huangjiang Ning ◽  
Youqing Wang

Automated closed-loop control of blood glucose concentration is a daily challenge for type 1 diabetes mellitus, where insulin and glucagon are two critical hormones for glucose regulation. According to whether glucagon is included, all artificial pancreas (AP) systems can be divided into two types: unihormonal AP (infuse only insulin) and bihormonal AP (infuse both insulin and glucagon). Even though the bihormonal AP is widely considered a promising direction, related studies are very scarce due to this system’s short research history. More importantly, there are few studies to compare these two kinds of AP systems fairly and systematically. In this paper, two switching rules, P-type and PD-type, were proposed to design the logic of orchestrates switching between insulin and glucagon subsystems, where the delivery rates of both insulin and glucagon were designed by using IMC-PID method. These proposed algorithms have been compared with an optimal unihormonal system on virtual type 1 diabetic subjects. Thein silicoresults demonstrate that the proposed bihormonal AP systems have outstanding superiorities in reducing the risk of hypoglycemia, smoothing the glucose level, and robustness with respect to insulin/glucagon sensitivity variations, compared with the optimal unihormonal AP system.


Sign in / Sign up

Export Citation Format

Share Document